2021 | Efficacy of Whole-Ventricular Radiotherapy in Patients Undergoing Maximal Tumor Resection for Glioblastomas Involving the Ventricle
| FRONTIERS IN ONCOLOGY |
2021 | Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma
| JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH |
2021 | Magnetic Resonance Imaging Parameters for Noninvasive Prediction of Epidermal Growth Factor Receptor Amplification in Isocitrate Dehydrogenase-Wild-Type Lower-Grade Gliomas: A Multicenter Study | NEUROSURGERY |
2021 | Reply to D'Alessandris et al.: Clear evidence of differences between tumor-resident mesenchymal stemlike cells and bone marrow-derived mesenchymal stem cells | NEURO-ONCOLOGY |
2021 | Quality assessment of meningioma radiomics studies: Bridging the gap between exploratory research and clinical applications | EUROPEAN JOURNAL OF RADIOLOGY |
2021 | Sensitive label-free imaging of brain samples using FxClear-based tissue clearing technique
| ISCIENCE |
2021 | Differentiation of recurrent diffuse glioma from treatment-induced change using amide proton transfer imaging: incremental value to diffusion and perfusion parameters | NEURORADIOLOGY |
2021 | Fully automated hybrid approach to predict the IDH mutation status of gliomas via deep learning and radiomics
| NEURO-ONCOLOGY |
2021 | Combinatorial Therapeutic Effect of Inhibitors of Aldehyde Dehydrogenase and Mitochondrial Complex I, and the Chemotherapeutic Drug, Temozolomide against Glioblastoma Tumorspheres
| MOLECULES |
2020 | Diffusion and perfusion MRI may predict EGFR amplification and the TERT promoter mutation status of IDH-wildtype lower-grade gliomas | EUROPEAN RADIOLOGY |
2020 | Co-expression ofcancer driver genes: IDH-wildtype glioblastoma-derived tumorspheres
| JOURNAL OF TRANSLATIONAL MEDICINE |
2020 | Ambient carbon monoxide exposure and elevated risk of mortality in the glioblastoma patients: A double-cohort retrospective observational study
| CANCER MEDICINE |
2020 | Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres
| JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
2020 | Crosstalk between GBM cells and mesenchymal stemlike cells promotes the invasiveness of GBM through the C5a/p38/ZEB1 axis | NEURO-ONCOLOGY |
2020 | Podoplanin-Targetable MR/OPTIC Dual-Mode Nanocomposites for Glioblastoma Multiforme in Mouse Brain Cancer
| DIGEST JOURNAL OF NANOMATERIALS AND BIOSTRUCTURES |
2020 | Magnetic resonance imaging-based 3-dimensional fractal dimension and lacunarity analyses may predict the meningioma grade | EUROPEAN RADIOLOGY |
2020 | Predicting survival using the 2016 World Health Organization classification for anaplastic glioma | CLINICAL NEUROPATHOLOGY |
2020 | Machine learning and radiomic phenotyping of lower grade gliomas: improving survival prediction | EUROPEAN RADIOLOGY |
2020 | ATM mutations improve radio-sensitivity in wild-type isocitrate dehydrogenase-associated high-grade glioma: retrospective analysis using next-generation sequencing data
| RADIATION ONCOLOGY |
2020 | Repotrectinib Exhibits Potent Antitumor Activity in Treatment-Naïve and Solvent-Front-Mutant ROS1-Rearranged Non-Small Cell Lung Cancer
| CLINICAL CANCER RESEARCH |
2020 | Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy
| SCIENTIFIC REPORTS |
2020 | Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities
| NATURE COMMUNICATIONS |
2020 | Silence of Hippo Pathway Associates with Pro-Tumoral Immunosuppression: Potential Therapeutic Target of Glioblastomas
| CELLS |
2020 | A Mechanism for microRNA Arm Switching Regulated by Uridylation | MOLECULAR CELL |
2020 | Deconvolution of Diffuse Gastric Cancer and the Suppression of CD34 on the BALB/c Nude Mice Model
| BMC CANCER |
2020 | Modeling Germline Mutations in Pineoblastoma Uncovers Lysosome Disruption-Based Therapy
| NATURE COMMUNICATIONS |
2020 | Diagnostic Challenges of Posterior Fossa Hemangioblastomas: Refining Current Radiological Classification Scheme
| SCIENTIFIC REPORTS |
2020 | Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas Without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study)
| CANCER RESEARCH AND TREATMENT |
2020 | Survival benefit of lobectomy over gross-total resection without lobectomy in cases of primary glioblastoma in non-eloquent area: a retrospective study | JOURNAL OF NEUROSURGERY |
2020 | Ttreatment results for recurrent glioblastoma and alteration of PD-L1 expression after recurrence | WORLD NEUROSURGERY |
2020 | Diffusion tensor imaging radiomics in lower-grade glioma: improving subtyping of isocitrate dehydrogenase mutation status | NEURORADIOLOGY |
2020 | Extent of resection and molecular pathologic subtype are potent prognostic factors of adult WHO grade II glioma
| SCIENTIFIC REPORTS |
2020 | Validation and optimization of a web-based nomogram for predicting survival of patients with newly diagnosed glioblastoma | STRAHLENTHERAPIE UND ONKOLOGIE |
2020 | Glioblastoma Cellular Origin and the Firework Pattern of Cancer Genesis from the Subventricular Zone
| JOURNAL OF KOREAN NEUROSURGICAL SOCIETY |
2019 | Effect of combined anti-PD-1 and temozolomide therapy in glioblastoma | ONCOIMMUNOLOGY |
2019 | The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade III Cerebral Gliomas in Adults: Version 2019.01
| Brain Tumor Research and Treatment |
2019 | The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade II Cerebral Gliomas in Adults: Version 2019.01
| Brain Tumor Research and Treatment |
2019 | Amide proton transfer imaging might predict survival and IDH mutation status in high-grade glioma | EUROPEAN RADIOLOGY |
2019 | Gossypol Suppresses Growth of Temozolomide-Resistant Glioblastoma Tumor Spheres
| Biomolecules |
2019 | Transcriptome profiling-based identification of prognostic subtypes and multi-omics signatures of glioblastoma
| Scientific Reports |
2019 | Re-evaluation of the diagnostic performance of 11C-methionine PET/CT according to the 2016 WHO classification of cerebral gliomas | European Journal of Nuclear Medicine and Molecular Imaging |
2019 | The Korean Society for Neuro-Oncology (KSNO) Guideline for Glioblastomas: Version 2018.01
| Brain Tumor Research and Treatment |
2019 | Relevance of a TCGA-derived Glioblastoma Subtype Gene-Classifier among Patient Populations
| SCIENTIFIC REPORTS |
2019 | Combined treatment with 2′-hydroxycinnamaldehyde and temozolomide suppresses glioblastoma tumorspheres by decreasing stemness and invasiveness | JOURNAL OF NEURO-ONCOLOGY |
2019 | Targeted next-generation sequencing panel (TruSight Tumor 170) in diffuse glioma: a single institutional experience of 135 cases | JOURNAL OF NEURO-ONCOLOGY |
2019 | Immune Checkpoint Inhibitor-induced Reinvigoration of Tumor-infiltrating CD8+ T Cells is Determined by Their Differentiation Status in Glioblastoma | CLINICAL CANCER RESEARCH |
2019 | Solitary fibrous tumor/hemangiopericytoma: treatment results based on the 2016 WHO classification | JOURNAL OF NEUROSURGERY |
2018 | MerTK mediates STAT3-KRAS/SRC-signaling axis for glioma stem cell maintenance | ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY |
2018 | Radiomic MRI Phenotyping of Glioblastoma: Improving Survival Prediction | RADIOLOGY |
2018 | Association analysis of RTEL1 variants with risk of adult gliomas in a Korean population
| PLOS ONE |